Tirzepatide

Description

Tirzepatide is a synthetic 39-amino-acid peptide functioning as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. In research settings, Tirzepatide is studied for its simultaneous engagement of two incretin receptor pathways and the resulting downstream metabolic signaling interactions.

BioRhex supplies Tirzepatide as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.